Stephen A. Bai

1.1k total citations
34 papers, 847 citations indexed

About

Stephen A. Bai is a scholar working on Pharmacology, Oncology and Hematology. According to data from OpenAlex, Stephen A. Bai has authored 34 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Oncology and 8 papers in Hematology. Recurrent topics in Stephen A. Bai's work include Drug Transport and Resistance Mechanisms (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Stephen A. Bai is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Stephen A. Bai collaborates with scholars based in United States, Germany and Netherlands. Stephen A. Bai's co-authors include Amy Manley, Evan Tzanis, Surya Chitra, Stephen Villano, Lynne Garrity-Ryan, Joyce A. Goldstein, Qinfang Xiang, J. G. Rêves, James R. Jacobs and A. L. Finn and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Stephen A. Bai

34 papers receiving 797 citations

Peers

Countries citing papers authored by Stephen A. Bai

Since Specialization

Citations

This map shows the geographic impact of Stephen A. Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Bai more than expected).

Fields of papers citing papers by Stephen A. Bai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Bai. The network helps show where Stephen A. Bai may publish in the future.

Co-authorship network of co-authors of Stephen A. Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen A. Bai. A scholar is included among the top collaborators of Stephen A. Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen A. Bai. Stephen A. Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria 2021 ·European Journal of Clinical Pharmacology ·Manfred Hauben, Stephen A. Bai, Eric Hung, Kasia Lobello, (unknown), (unknown)	4
2	The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study 2020 ·European Journal of Drug Metabolism and Pharmacokinetics ·Thomas L. Hunt, Evan Tzanis, Stephen A. Bai, Amy Manley, Surya Chitra, Paul C. McGovern	16
3	Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers 2016 ·Clinical Therapeutics ·Stephen A. Bai, Qinfang Xiang, A. L. Finn	27
4	Effect of Food on the Bioavailability of Omadacycline in Healthy Participants 2016 ·The Journal of Clinical Pharmacology ·Evan Tzanis, Amy Manley, Stephen Villano, Sébastien Tanaka, Stephen A. Bai, Evan Loh	37
5	A Subcutaneous Octreotide Hydrogel Implant for the Treatment of Acromegaly 2012 ·Endocrine Practice ·Mônica R. Gadelha, (unknown), Stephen A. Bai, Xiaojun Hu, Lawrence A. Frohman	11
6	Pharmacokinetics and Pharmacodynamics of the Erythropoietin Mimetibody™ Construct CNTO 528 in Healthy Subjects 2009 ·Clinical Pharmacokinetics ·Juan José Pérez Ruixo, Wojciech Krzyżański, Esther Bouman‐Thio, Bruce Miller, Haishan Jang, Stephen A. Bai, Honghui Zhou, (unknown), Adam F. Cohen, Jacobus Burggraaf, Kari L. Franson, Hugh M. Davis	31
7	A Phase I, Single and Fractionated, Ascending‐Dose Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of an Erythropoietin Mimetic Antibody Fusion Protein (CNTO 528) in Healthy Male Subjects 2008 ·The Journal of Clinical Pharmacology ·Esther Bouman‐Thio, Kari L. Franson, Bruce Miller, (unknown), Adam F. Cohen, Stephen A. Bai, (unknown), Bart Frederick, Stanley J. Marciniak, Qun Jiao, Haishan Jang, Hugh M. Davis, Jacobus Burggraaf	31
8	Pharmacokinetics and Pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-Amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a Potent and Selective Inhibitor of Tumor Necrosis Factor α-Converting Enzyme in Rodents, Dogs, Chimpanzees, and Humans 2007 ·Drug Metabolism and Disposition ·Mingxin Qian, Stephen A. Bai, Bernice L. Brogdon, Jing‐Tao Wu, Rui‐Qin Liu, Maryanne Covington, Kris Vaddi, Robert Newton, Michael J. Fossler, C. Edwin Garner, Yuzhong Deng, Thomas Maduskuie, James M. Trzăskos, James J.‐W. Duan, Carl P. Decicco, David D. Christ	42
9	Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa 2006 ·Bioorganic & Medicinal Chemistry Letters ·Yunlong Li, John M. Fevig, Joseph Cacciola, (unknown), Karen A. Rossi, Janan Jona, Robert M. Knabb, Joseph M. Luettgen, Pancras C. Wong, Stephen A. Bai, Ruth R. Wexler, Patrick Y. S. Lam	24
10	Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa 2006 ·Bioorganic & Medicinal Chemistry Letters ·John M. Fevig, Joseph Cacciola, (unknown), Karen A. Rossi, Robert M. Knabb, Joseph M. Luettgen, Pancras C. Wong, Stephen A. Bai, Ruth R. Wexler, Patrick Y. S. Lam	43
11	THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION 2004 ·Drug Metabolism and Disposition ·Harvey Wong, Scott Grossman, Stephen A. Bai, Sharon Diamond, Matthew Wright, James E. Grace, Mingxin Qian, Kan He, Krishnaswamy Yeleswaram, David D. Christ	21
12	Pharmacokinetic-Pharmacodynamic Relations of Losartan and EXP3174 in a Porcine Animal Model 1997 ·Journal of Cardiovascular Pharmacology ·(unknown), (unknown), Peter W. Hellyer, David D. Christ, Stephen A. Bai	11
13	Determination of concentration of albendazole sulfoxide in plasma and uterine fluid of heifers 1997 ·American Journal of Veterinary Research ·(unknown), Charlotte E. Farin, Stephen A. Bai	1
14	Pharmacokinetic and Pharmacodynamic Properties of Conventional and CD-Formulated Diltiazem in Cats 1996 ·Journal of Veterinary Internal Medicine ·(unknown), Clarke E. Atkins, Bruce W. Keene, Stephen A. Bai	12
15	Orthodromic Reciprocating Tachycardia and Heart Failure in a Dog With a Concealed Posteroseptal Accessory Pathway 1995 ·Journal of Veterinary Internal Medicine ·Clarke E. Atkins, Ronald J. Kanter, Kathy N. Wright, (unknown), Catherine J. Baty, (unknown), Stephen A. Bai, Bruce W. Keene	28
16	Determination of the stereochemical composition of the major metabolites of verapamil in dog urine with enantioselective liquid chromatographic techniques 1995 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown), Stephen A. Bai	19
17	Pharmacokinetics of the enantiomers of verapamil in the dog 1993 ·Chirality ·Stephen A. Bai, (unknown), (unknown)	16
18	Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet 1987 ·Clinical Pharmacology & Therapeutics ·Timothy C. Fagan, Thomas Walle, Mary Joan Oexmann, U. Kristina Walle, Stephen A. Bai, Thomas E. Gaffney	42
19	Effects of chlorpromazine on the disposition and beta-adrenergic blocking activity of propranolol in the dog 1984 ·Journal of Pharmacokinetics and Biopharmaceutics ·Stephen A. Bai, Fred P. Abramson	4
20	Relationships between propranolol plasma protein binding, glycoprotein concentration, and enzyme induction following phenobarbital administration in the dog 1983 ·Biochemical Pharmacology ·Fred P. Abramson, Denise E. Robinson, Stephen A. Bai	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact